Company / Free Cash Flow per Share
FATE THERAPEUTICS INC Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.08
FY2025
5-year range
-$2.92 / -$0.46
FY2021-FY2025
Trend
+22.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-2.92 in FY2023 to $-0.46 in FY2022.
Based on SEC 10-K filings.
-1.08 in FY2025.
Improved from $-2.92 to $-1.08 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 22.7% year-over-year.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.08 | +22.7% |
| FY2024 | -$1.40 | +51.9% |
| FY2023 | -$2.92 | -532.2% |
| FY2022 | -$0.46 | +55.3% |
| FY2021 | -$1.03 | -90.9% |
| FY2020 | -$0.54 | +9.2% |
| FY2019 | -$0.60 | -3.6% |
| FY2018 | -$0.58 | -19.6% |
| FY2017 | -$0.48 | +40.8% |
| FY2016 | -$0.81 | -6.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026